• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Third Rock Ventures

edit

Third Rock Ventures invests in transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace.

Recent Milestones

edit

• 
  Third Rock Ventures invested in TARIS Biomedical. (4/2/13)
  Posted 4/5/13 at 5:42am via pehub.com
• 
  Third Rock Ventures invested in DC Devices. (3/21/13)
  Posted 3/25/13 at 10:36pm via finsmes.com
• 
  Third Rock Ventures invested in Kala Pharmaceuticals. (2/28/13)
  Posted 2/28/13 at 6:27pm via finsmes.com
• 
  Third Rock Ventures invested in Jounce Therapeutics. (2/14/13)
  Posted 2/14/13 at 7:56pm via finsmes.com
• 
  Third Rock Ventures invested in Zafgen. (12/4/12)
  Posted 12/5/12 at 2:43am via masshightech.com
• 
  Third Rock Ventures invested in Rhythm Pharmaceuticals. (11/27/12)
  Posted 11/27/12 at 7:45pm via pehub.com
• 
  Third Rock Ventures invested in Cibiem. (10/17/12)
  Posted 10/18/12 at 4:45am via finsmes.com
• 
  Third Rock Ventures invested in MyoKardia. (9/20/12)
  Posted 9/20/12 at 6:33pm via finsmes.com
• 
  Third Rock Ventures invested in Foundation Medicine. (9/20/12)
  Posted 9/20/12 at 6:14pm via finsmes.com
• 
  Third Rock Ventures invested in bluebird bio. (7/25/12)
  Posted 7/25/12 at 4:35am via yahoo.com
• 
  Third Rock Ventures invested in Global Blood Therapeutics. (6/14/12)
  Posted 6/14/12 at 4:50am via finsmes.com
• 
  Third Rock Ventures invested in Rhythm Pharmaceuticals. (6/13/12)
  Posted 6/13/12 at 6:14pm via rhythmtx.com
• 
  Third Rock Ventures invested in Igenica. (6/12/12)
  Posted 6/12/12 at 6:45pm via finsmes.com
• 
  Third Rock Ventures invested in Eleven Biotherapeutics. (5/8/12)
  Posted 5/8/12 at 5:03am via masshightech.com
• 
  Third Rock Ventures invested in Alcresta. (4/17/12)
  Posted 4/17/12 at 9:10pm via finsmes.com
• 
  Third Rock Ventures invested in Kala Pharmaceuticals. (3/14/12)
  Posted 3/14/12 at 5:48am via finsmes.com

Investments

Videos

Sources

1. Third Rock Ventures Closes $426M Venture Capital Fund (finsmes.com) [edit]
2. Third Rock Ventures gets its hands dirty with $516M for healthcare startups (venturebeat.com) [edit]
Third Rock fund hits $426 million (masshightech.com) [edit]
Third Rock Ventures adds biologics expert Kamen (masshightech.com) [edit]
3. Taris Biomedical Raises $12.5 Million (pehub.com) [edit]
4. DC Devices Secures $9M in Financing (finsmes.com) [edit]
5. Kala Pharmaceuticals Raises $11.5M in Series A Equity Financing (finsmes.com) [edit]
6. Jounce Therapeutics Raises $47M in Series A Financing from Third Rock Ventures (finsmes.com) [edit]
7. Obesity drug developer Zafgen raises $21M (masshightech.com) [edit]
8. Rhythm Adds $8M to Cap Series B at $33M (pehub.com) [edit]
9. Cibiem Raises $10M in Series A Financing (finsmes.com) [edit]
10. MyoKardia Raises $38M in Series A Financing (finsmes.com) [edit]
11. Foundation Medicine Closes $42.5M Series B Funding (finsmes.com) [edit]
12. bluebird bio Secures $60 Million in Oversubscribed Financing (in.finance.yahoo.com) [edit]
13. Global Blood Therapeutics Raises $40.7M in Series A Financing (finsmes.com) [edit]
14. Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics (rhythmtx.com) [edit]
15. Igenica Raises $33M in Series C Funding (finsmes.com) [edit]
16. Eleven Biotherapeutics rakes in $20M fundraise (masshightech.com) [edit]
17. Alcresta Raises $10M in Series A Financing (finsmes.com) [edit]
18. Kala Pharmaceuticals Raises $6.2M in Equity Financing (finsmes.com) [edit]
19. Warp Drive Bio Raises $125M (finsmes.com) [edit]
20. Third Rock Ventures Launches Ember Therapeutics Secures $34 Million Series A to Accelerate Drug Discovery & Development (embertx.com) [edit]
21. Agios Pharmaceuticals Raises $78M in Series C Financing (finsmes.com) [edit]
22. Allena Pharmaceuticals Raises $15M in Series A Venture Capital Financing (finsmes.com) [edit]
23. TOPICA Pharmaceuticals Raises $27M in Series B Funding (finsmes.com) [edit]
24. SAGE Therapeutics Raises $35M in Series A Funding from Third Rock Ventures (finsmes.com) [edit]
25. Foundation Medicine Closes $33.5M Expanded Series A Financing (finsmes.com) [edit]
26. Zafgen Secures $33 Million Series C Financing (eon.businesswire.com) [edit]
27. Lotus Tissue Repair, Inc. Secures $26 Million Series A Financing to Develop First-in-Class Protein Replacement Therapy for Dystrophic Epidermolysis Bullosa (financial.businessinsider.com) [edit]
28. Constellation Pharmaceuticals Raises $15M in Series B Financing (finsmes.com) [edit]
29. Seventh Sense Biosystems Secures $4.5M from $10M Series A Offering (7sbio.com) [edit]
30. bluebird bio Secures Additional $30 Million in Financing; ARCH Venture Partners Joins Investor Team (live-pr.com) [edit]
31. TARIS Closes $18.3 Million Series B Financing (eon.businesswire.com) [edit]
32. Blueprint Medicines Secures $40 Million Series A Financing to Translate New Molecular Data into Personalized Cancer Treatments (blueprintmedicines.com) [edit]
33. PanOptica Raises $30m in Series A Financing (finsmes.com) [edit]
34. NinePoint Medical Completes $33 Million Series A Financing (fiercebiotech.com) [edit]
35. CytomX Therapeutics Completes $30M Series B Financing (finsmes.com) [edit]
36. Constellation Pharmaceuticals, Inc.: Series B $4.8M (onbiovc.com) [edit]
37. Ablexis, LLC: Series A $12M (onbiovc.com) [edit]
38. ZafGen, Inc.: Series B $8.1M (onbiovc.com) [edit]
39. Genetix raises $35M to advance gene therapies (fiercebiotech.com) [edit]
40. Eleven Biotherapeutics, Inc.: Series A $35M (onbiovc.com) [edit]
41. Afferent Pharmaceuticals Closes $23M Series A Financing Round (finsmes.com) [edit]
42. Constellation Pharmaceuticals, Inc. Closes $17 Million in Funding (constellationpharma.com) [edit]
43. Alnara Pharmaceuticals Inc Obtains $20,000,000 Series A Round (xconomy.com) [edit]